New $3.26 million grant launches Undiagnosed Diseases Network site in New York

A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), establishes the first Undiagnosed Diseases Network (UDN) site in the New York metropolitan area.

BioNTech and Duality Bio add another investigational drug to oncology partnership – Pharmaceutical Technology

BioNTech has reported a sharp decline in revenue in H1 2023, generating only €1.44bn ($1.59bn) in the six months compared to €9.57 bn($10.5bn) it generated

August 7, 2023

UK NICE recommends Accord’s Relugolix for prostate cancer

Relugolix offers a more convenient and flexible treatment option than injectable therapies. Credit: NICE. The UK National Institute for Health and Care Excellence (Nice) has

July 22, 2024

Doctors divide over reforming a secretive panel that determines their Medicare pay

WASHINGTON — Doctors are splitting, specialty by specialty, over whether and how to overhaul a secretive panel that helps determine how much Medicare pays them

November 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.